The Cambridge Independent Science and Technology Awards 2018

Cambridge Start-Up of the Year

Elpis Wins 2018 Cambridge Independent Start-Up of the Year Award Elpis was voted as the 2018 Cambridge Start-Up of the Year among a highly competitive field of life science and biotech start-ups. The Cambridge Independent Science and Technology Awards are sponsored by local technology heavyweights such as AstraZeneca / MedImmune and Read more…

Jonathan Milner

Elpis human cell models could potentially replace animal experiments in drug discovery

Dr Jonathan Milner mentioned Elpis during his plenary lecture at the 2018 European Laboratory Research & Innovation Group (ELRIG) Drug Discovery Conference, stating, “Elpis human cells can fix the broken drug discovery process by replacing animal experiments.”  He added, “Elpis provides the first robust and scalable solution of functional biologically-relevant cells Read more…

Elpis closes funding round

Elpis has closed a funding round backed by top life sciences investors. The funds will be used to grow the company’s catalogue of human cell type products and expand its service offerings. This marks our first step towards more complex products, including human organ-on-chip models, and cell-based therapies. Jonathan Milner Read more…

Elpis receives Innovate UK grant

Elpis has received a grant from Innovate UK to investigate the use of its technology for cell therapy. The project will look at the feasibility of using Elpis oligodendrocytes (a nervous system support cell) as therapy for spinal cord injury. This is a promising application of the technology for cell Read more…